$659 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 67 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 45.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | $53,362,000 | -17.9% | 2,628,678 | 0.0% | 8.10% | -37.8% | |
| VERU | New | VERU INC | $52,323,000 | – | 4,630,339 | +100.0% | 7.94% | – |
| ALT | Buy | ALTIMMUNE INC | $42,125,000 | +168.8% | 3,600,450 | +39.9% | 6.39% | +103.8% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $40,799,000 | – | 280,000 | +100.0% | 6.19% | – |
| ITCI | INTRA-CELLULAR THERAPIES INC | $39,956,000 | -6.7% | 700,000 | 0.0% | 6.06% | -29.2% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $30,649,000 | -25.3% | 9,607,934 | 0.0% | 4.65% | -43.3% | |
| TARS | Buy | TARSUS PHARMACEUTICALS INC | $30,432,000 | +503.1% | 2,084,370 | +594.8% | 4.62% | +357.7% |
| BIO | Buy | BIO RAD LABS INCcl a | $29,205,000 | +29.6% | 59,000 | +47.5% | 4.43% | -1.7% |
| BLUE | Buy | BLUEBIRD BIO INC | $24,470,000 | +225.5% | 5,910,687 | +281.3% | 3.71% | +146.9% |
| ITOS | ITEOS THERAPEUTICS INC | $19,313,000 | -36.0% | 937,500 | 0.0% | 2.93% | -51.4% | |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $17,712,000 | +85.4% | 1,800,000 | +177.7% | 2.69% | +40.7% |
| RCKT | ROCKET PHARMACEUTICALS INC | $17,419,000 | -13.2% | 1,265,900 | 0.0% | 2.64% | -34.2% | |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | $14,631,000 | +0.2% | 300,000 | 0.0% | 2.22% | -24.0% | |
| Buy | INSPIRATO INCORPORATED | $14,611,000 | +71.9% | 3,155,738 | +268.9% | 2.22% | +30.3% | |
| IMCR | IMMUNOCORE HLDGS PLCads | $14,387,000 | +24.8% | 385,600 | 0.0% | 2.18% | -5.3% | |
| GLPG | GALAPAGOS NVspon adr | $13,950,000 | -10.0% | 250,000 | 0.0% | 2.12% | -31.8% | |
| ALBO | Buy | ALBIREO PHARMA INC | $13,902,000 | -0.4% | 700,000 | +49.7% | 2.11% | -24.4% |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $12,696,000 | – | 1,200,000 | +100.0% | 1.93% | – |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $10,561,000 | +27.5% | 3,641,606 | +21.4% | 1.60% | -3.3% |
| HRTX | HERON THERAPEUTICS INC | $10,379,000 | -51.2% | 3,720,000 | 0.0% | 1.58% | -63.0% | |
| BCAB | Buy | BIOATLA INC | $9,613,000 | +74.8% | 3,373,000 | +206.6% | 1.46% | +32.6% |
| CGEM | New | CULLINAN ONCOLOGY INC | $7,810,000 | – | 609,231 | +100.0% | 1.18% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $7,596,000 | – | 400,000 | +100.0% | 1.15% | – |
| IONS | IONIS PHARMACEUTICALS INC | $7,404,000 | -0.1% | 200,000 | 0.0% | 1.12% | -24.2% | |
| IMGN | IMMUNOGEN INC | $6,750,000 | -5.5% | 1,500,000 | 0.0% | 1.02% | -28.3% | |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $6,509,000 | -8.6% | 137,700 | +37.7% | 0.99% | -30.6% |
| BNTX | BIONTECH SEsponsored ads | $5,964,000 | -12.6% | 40,000 | 0.0% | 0.90% | -33.7% | |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $5,814,000 | +17.0% | 600,000 | +20.0% | 0.88% | -11.3% |
| BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $5,684,000 | – | 50,000 | +100.0% | 0.86% | – |
| BLU | BELLUS HEALTH INC NEW | $5,544,000 | +34.3% | 600,000 | 0.0% | 0.84% | +1.8% | |
| CHRS | COHERUS BIOSCIENCES INC | $5,430,000 | -43.9% | 750,000 | 0.0% | 0.82% | -57.5% | |
| RCUS | ARCUS BIOSCIENCES INC | $5,068,000 | -19.7% | 200,000 | 0.0% | 0.77% | -39.1% | |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $4,628,000 | – | 400,000 | +100.0% | 0.70% | – |
| NKTX | Buy | NKARTA INC | $4,312,000 | +89.5% | 350,000 | +75.0% | 0.65% | +43.7% |
| ALLK | ALLAKOS INC | $4,142,000 | -45.1% | 1,323,393 | 0.0% | 0.63% | -58.4% | |
| GNFT | Buy | GENFIT S Aads | $4,062,000 | -13.3% | 1,261,442 | +7.7% | 0.62% | -34.3% |
| 2SEVENTY BIO INC | $3,960,000 | -22.6% | 300,000 | 0.0% | 0.60% | -41.3% | ||
| New | PYXIS ONCOLOGY INC | $3,282,000 | – | 1,379,080 | +100.0% | 0.50% | – | |
| CRVS | Buy | CORVUS PHARMACEUTICALS INC | $3,269,000 | -35.7% | 3,301,709 | +6.4% | 0.50% | -51.3% |
| LIFE | ATYR PHARMA INC | $3,151,000 | -47.1% | 1,113,453 | 0.0% | 0.48% | -59.9% | |
| Buy | TRITIUM DCFC LIMITEDordinary shares | $3,045,000 | +144.2% | 500,000 | +302.6% | 0.46% | +85.5% | |
| GRPH | New | GRAPHITE BIO INC | $3,025,000 | – | 1,100,000 | +100.0% | 0.46% | – |
| ANIP | ANI PHARMACEUTICALS INC | $2,967,000 | +5.5% | 100,000 | 0.0% | 0.45% | -19.9% | |
| FBIO | Buy | FORTRESS BIOTECH INC | $2,808,000 | -12.1% | 3,342,801 | +42.2% | 0.43% | -33.3% |
| VNDA | VANDA PHARMACEUTICALS INC | $2,798,000 | -3.6% | 256,696 | 0.0% | 0.42% | -26.9% | |
| LEGN | LEGEND BIOTECH CORPsponsored ads | $2,750,000 | +51.3% | 50,000 | 0.0% | 0.42% | +14.9% | |
| ASLN | Buy | ASLAN PHARMACEUTICALS LTDads | $2,750,000 | -7.0% | 5,554,925 | +69.0% | 0.42% | -29.6% |
| Buy | TSCAN THERAPEUTICS INC | $2,352,000 | +320.0% | 747,800 | +273.9% | 0.36% | +218.8% | |
| TANGO THERAPEUTICS INC | $2,123,000 | -40.2% | 468,750 | 0.0% | 0.32% | -54.7% | ||
| MIRM | New | MIRUM PHARMACEUTICALS INC | $1,946,000 | – | 100,000 | +100.0% | 0.30% | – |
| CTMX | New | CYTOMX THERAPEUTICS INC | $1,930,000 | – | 1,054,673 | +100.0% | 0.29% | – |
| ALGS | New | ALIGOS THERAPEUTICS INC | $1,873,000 | – | 1,547,710 | +100.0% | 0.28% | – |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $1,675,000 | – | 319,043 | +100.0% | 0.25% | – | |
| NKTR | NEKTAR THERAPEUTICS | $1,634,000 | -29.5% | 430,037 | 0.0% | 0.25% | -46.6% | |
| LPTX | LEAP THERAPEUTICS INC | $1,438,000 | -34.3% | 1,250,000 | 0.0% | 0.22% | -50.2% | |
| VINC | VINCERX PHARMA INC | $1,360,000 | -67.0% | 1,030,634 | 0.0% | 0.21% | -75.0% | |
| RVPH | REVIVA PHARMACEUTCLS HLDGS I | $1,320,000 | -55.3% | 1,200,000 | 0.0% | 0.20% | -66.2% | |
| OLMA | New | OLEMA PHARMACEUTICALS INC | $1,298,000 | – | 318,926 | +100.0% | 0.20% | – |
| CCXI | New | CHEMOCENTRYX INC | $1,239,000 | – | 50,000 | +100.0% | 0.19% | – |
| EQ | EQUILLIUM INC | $1,224,000 | -35.2% | 600,000 | 0.0% | 0.19% | -50.8% | |
| ORTX | New | ORCHARD THERAPEUTICS PLCads | $1,168,000 | – | 2,000,000 | +100.0% | 0.18% | – |
| ALEC | ALECTOR INC | $1,016,000 | -28.7% | 100,000 | 0.0% | 0.15% | -46.0% | |
| Sell | INSPIRATO INCORPORATED*w exp 02/11/2027 | $761,000 | -72.0% | 1,170,000 | -16.4% | 0.12% | -78.8% | |
| FIXX | HOMOLOGY MEDICINES INC | $423,000 | -35.2% | 214,898 | 0.0% | 0.06% | -51.1% | |
| New | PARDES BIOSCIENCES INC | $417,000 | – | 135,963 | +100.0% | 0.06% | – | |
| New | ROIVANT SCIENCES LTD | $413,000 | – | 101,404 | +100.0% | 0.06% | – | |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $408,000 | – | 200,000 | +100.0% | 0.06% | – |
| Exit | SKY HARBOUR GROUP CORPORATIO*w exp 01/23/2027 | $0 | – | -459,611 | -100.0% | -0.14% | – | |
| Exit | NEKTAR THERAPEUTICScall | $0 | – | -539,600 | -100.0% | -0.58% | – | |
| Exit | NEKTAR THERAPEUTICSput | $0 | – | -539,600 | -100.0% | -0.58% | – | |
| Exit | BRC INC*w exp 02/09/2027 | $0 | – | -805,900 | -100.0% | -0.72% | – | |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -300,000 | -100.0% | -1.92% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 37 | Q3 2023 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 20 | Q3 2023 | 31.6% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| ANAPTYSBIO INC | 16 | Q3 2023 | 18.4% |
| COHERUS BIOSCIENCES INC | 15 | Q3 2023 | 2.7% |
| EQUILLIUM INC | 13 | Q3 2023 | 1.2% |
| RELMADA THERAPEUTICS INC | 12 | Q4 2022 | 6.2% |
| MIRATI THERAPEUTICS INC | 11 | Q3 2023 | 10.9% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-13 |
| 13F-HR | 2023-08-14 |
| 3 | 2023-06-01 |
| 4 | 2023-06-01 |
| 4 | 2023-05-30 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.